DigestRedComo funciona
Red
/
Empresas
Tu
No verificado

Tubulis

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaOncologíaSalud

14 Comunicados de prensa

Ver todos los comunicados de prensa
27/01/2026
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Mercado laboral
Tubulis Adds Steve Kelsey as Independent Director to its Advisory Board
Fuente
Tubulis
Editor
Business Wire
1.00
0
21/01/2026
Ciencia
Biotecnología
Farmacéutica
Oncología
Salud
Industria
Tubulis Unveils Alco5 Conjugation Platform’s Ability to Expand ADC Payload Scope in Nature Communications
Fuente
Tubulis
Editor
Business Wire
1.00
0
08/01/2026
Ciencia
Biotecnología
Farmacéutica
Oncología
Sanidad
Salud
Medicina - Varios
Mercado laboral
Tubulis Appoints Charles Fuchs, MD as Chief Medical Officer to Lead Clinical Strategy and Pipeline Development
Fuente
Tubulis
Editor
Business Wire
1.00
0
16/12/2025
Eventos
Sanidad
Salud
Farmacéutica
Medicina - Varios
Oncología
Tubulis to Present at the 44th Annual J.P. Morgan Healthcare Conference
Fuente
Tubulis
Editor
Business Wire
1.00
0
30/10/2025
Biotecnología
Sanidad
Salud
Farmacéutica
Oncología
Ciencia
Ir de compras
Medicina - Varios
Tubulis Announces Second Closing of Series C Bringing Total Raised to €344M (US $401M)
Fuente
Tubulis
Editor
Business Wire
1.00
0
19/10/2025
Ciencia
Medicina - Varios
Biotecnología
Farmacéutica
Ir de compras
Salud
Oncología
Eventos
Industria
Tubulis Presents First Clinical Data from Phase I/IIa Trial for TUB-040 in Platinum-Resistant Ovarian Cancer (PROC) at ESMO 2025
Fuente
Tubulis
Editor
Business Wire
1.00
0
15/10/2025
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Tubulis Raises €308 Million Series C to Accelerate Clinical Development of Lead ADC Candidate TUB-040 and Expand Pipeline
Fuente
Tubulis
Editor
Business Wire
1.00
0
22/09/2025
Eventos
Industria
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Tubulis to Present First Phase I/IIa Trial Data for ADC Candidate TUB-040 in Platinum-Resistant Ovarian Cancer in Late-Breaking Oral Presentation at ESMO 2025
Fuente
Tubulis
Editor
Business Wire
1.00
0
09/09/2025
Ciencia
Legislación/Derecho
Biotecnología
Farmacéutica
Oncología
Salud
Asociaciones/Profesionales
Mercado laboral
Tubulis Strengthens Leadership Team with Appointment of Halley Gilbert as Chief Legal and Operating Officer
Fuente
Tubulis
Editor
Business Wire
1.00
0
06/02/2025
Oncología
Salud
Ciencia
Farmacéutica
Biotecnología
Mercado laboral
Tubulis Strengthens Executive Leadership with Appointment of Matthew Norkunas as Chief Financial Officer and President of Tubulis Inc.
Fuente
Tubulis
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0